Stryker (SYK) Shares Outstanding (Diluted Average) (2009 - 2026)

Stryker (SYK) reported Shares Outstanding (Diluted Average) of $386.5 million for Q1 2026, little changed year-over-year from $386.4 million in Q1 2025, and little changed quarter-over-quarter from $386.5 million in Q4 2025.

Stryker (SYK) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Shares Outstanding (Diluted Average) data on file, last reported at $386.5 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $386.5 million, changed 0.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $386.5 million (changed 0.03% YoY), and the FY2025 annual result was $386.5 million, up 8302.17% from the prior year.
  • Shares Outstanding (Diluted Average) steadied at $386.5 million in Q1 2026 per SYK's latest filing, from $386.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $386.5 million in Q4 2025 and troughed at $4.0 million in Q4 2022.
  • A 5-year average of $227.9 million and a median of $382.5 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) surged 9492.5% in 2023, then tumbled 98.88% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $4.0 million in 2022, then surged by 9492.5% to $383.7 million in 2023, then slumped by 98.8% to $4.6 million in 2024, then soared by 8302.17% to $386.5 million in 2025, then changed by 0.0% to $386.5 million in 2026.
  • Business Quant data shows SYK's Shares Outstanding (Diluted Average) at $386.5 million in Q1 2026, $386.5 million in Q4 2025, and $4.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.75 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 386.50 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 457.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 386.50 Mn
Dec 31, 2025 386.50 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 4.20 Mn
Mar 31, 2025 386.40 Mn
Dec 31, 2024 4.60 Mn
Sep 30, 2024 385.40 Mn
Jun 30, 2024 4.40 Mn
Mar 31, 2024 4.70 Mn
Dec 31, 2023 383.70 Mn
Sep 30, 2023 384.00 Mn
Jun 30, 2023 383.60 Mn
Mar 31, 2023 383.20 Mn
Dec 31, 2022 4.00 Mn
Sep 30, 2022 381.80 Mn
Jun 30, 2022 382.50 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 5.30 Mn
Sep 30, 2021 5.60 Mn
Jun 30, 2021 5.40 Mn